Your browser doesn't support javascript.
loading
Clinical Characteristics and Glycemic Outcomes of Patients with Type 2 Diabetes Requiring Maximum Dose Insulin Glargine/Lixisenatide Fixed-Ratio Combination or Insulin Glargine in the LixiLan-L Trial.
Blonde, Lawrence; Bailey, Timothy S; Chao, Jason; Dex, Terry A; Frias, Juan Pablo; Meneghini, Luigi F; Roberts, Michelle; Aroda, Vanita R.
Afiliação
  • Blonde L; Department of Endocrinology, Ochsner Medical Center, New Orleans, LA, USA. lblonde@ochsner.org.
  • Bailey TS; AMCR Institute, Inc., Escondido, CA, USA.
  • Chao J; Xinyi, Inc., Bridgewater, NJ, USA.
  • Dex TA; Sanofi US, Inc., Bridgewater, NJ, USA.
  • Frias JP; National Research Institute, Los Angeles, CA, USA.
  • Meneghini LF; UT Southwestern Medical Center and Parkland Health and Hospital System, Dallas, TX, USA.
  • Roberts M; Sanofi US, Inc., Bridgewater, NJ, USA.
  • Aroda VR; Brigham and Women's Hospital, Boston, MA, USA.
Adv Ther ; 36(9): 2310-2326, 2019 09.
Article em En | MEDLINE | ID: mdl-31359368
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article